Valuation: Tofflon Science and Technology Group Co., Ltd.

Market Cap 10.41B 1.54B 1.33B 1.25B 1.14B 2.14B 148B 2.18B 14.71B 5.77B 73.96B 5.79B 5.67B 246B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 6.99B 1.04B 896M 843M 766M 1.44B 99.37B 1.46B 9.89B 3.87B 49.7B 3.89B 3.81B 166B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.48x
Free-Float
25.51%
Yield 2026 *
0.95%
Yield 2027 * 1.61%
05-25 Tofflon Science and Technology Group Co., Ltd. Announces 2025 Final Profit Distribution Plan on A Shares, Payable on June 1, 2026 CI
04-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-28 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/10/25 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
16/09/25 Tofflon Science and Technology Group Co., Ltd. Approves Interim Cash Dividend on A Shares for the Year 2025, Payable on September 25, 2025 CI
28/08/25 Tofflon Science and Technology Group Co., Ltd. Proposes Interim Cash Dividend for the Year 2025 CI
27/08/25 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
13/06/25 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component A Share Index CI
13/06/25 Tofflon Science and Technology Group Co., Ltd.(SZSE:300171) dropped from Shenzhen Stock Exchange Component Index CI
21/05/25 Tofflon Science and Technology Group Co., Ltd. Approves Cash Dividend on Share A for 2024 CI
25/04/25 Tofflon Science and Technology Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024 CI
24/04/25 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
24/04/25 Tofflon Science and Technology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
1 day-2.84%
1 week-0.80%
Current month+12.32%
1 month+17.12%
3 months+8.83%
6 months-18.18%
Current year-12.87%
1 week 13.55
Extreme 13.55
14.88
1 month 11.42
Extreme 11.42
14.88
Current year 10.42
Extreme 10.42
20.37
1 year 10.42
Extreme 10.42
20.37
3 years 9.6
Extreme 9.6
21
5 years 9.6
Extreme 9.6
68
10 years 5.16
Extreme 5.16
68
Manager TitleAgeSince
Chief Executive Officer 62 01/01/1993
Director of Finance/CFO 45 01/07/2012
Corporate Officer/Principal 57 01/01/2001
Director TitleAgeSince
Chairman 62 01/03/2008
Director/Board Member 54 30/03/2008
Director/Board Member 53 30/03/2008
Date Insider Type Main position Quantity % Market Cap.
05/02/24 Buy

Chief Executive Officer

40,000 0.0072%
01/02/24 Buy

Chief Executive Officer

30,000 0.0054%
17/01/24 Buy

Chief Executive Officer

80,000 0.0143%
Change 5-day change 1-year change 3-year change Capi.($)
-2.84%-0.80%-10.41%-34.42% 1.54B
-1.19%-3.37%+38.86%+160.01% 131B
-3.53%-9.78%+34.76%+50.33% 36.74B
+0.83%-3.60%+2.34%+22.50% 31.34B
-5.70%-9.46%+52.17%+6.65% 29.62B
+1.75%+9.79%+644.08%+2,132.23% 29.32B
-0.14%-2.23%+13.20%+45.41% 27.35B
+1.46%-5.19%-18.49%+15.70% 26.6B
-0.89%-3.29%+24.26%+50.08% 23.87B
-1.08%-3.58% - - 23.61B
Average -1.20%-2.67%+86.75%+272.05% 36.14B
Weighted average by Cap. -1.24%-2.48%+80.87%+263.75%

Financials

2026 *2027 *
Net sales 5.67B 841M 727M 684M 621M 1.17B 80.62B 1.19B 8.02B 3.14B 40.32B 3.16B 3.09B 134B 6.24B 925M 799M 752M 683M 1.29B 88.63B 1.3B 8.82B 3.46B 44.33B 3.47B 3.4B 148B
Net income - -
Net Debt -3.41B -506M -437M -411M -374M -703M -48.52B -714M -4.83B -1.89B -24.27B -1.9B -1.86B -80.83B -1.15B -170M -147M -138M -126M -237M -16.32B -240M -1.62B -636M -8.16B -639M -626M -27.19B
Logo Tofflon Science and Technology Group Co., Ltd.
Tofflon Science and Technology Group Co Ltd is a China-based company mainly engaged in the research, development, production, and sales of pharmaceutical equipment, and the provision of technical services. The Company mainly operates four businesses. The bioprocessing business mainly provides equipment, instruments, and consumables such as fermentation systems, precision packaging systems, and traditional Chinese medicine extraction systems. The pharmaceutical preparations business mainly provides equipment and instruments required for the preparation of injectable dosage forms, oral solid dosage forms, and the inspection and packaging of finished drugs. The integrated engineering solutions business mainly provides information system software and intelligent manufacturing integrated solutions. The food engineering business is mainly engaged in the manufacturing of equipment for the liquid food sector, and the provision of system solutions, process engineering, and overall solutions.
Employees
5,479
Date Price Change Volume
18/08/26 CN¥13.68 -2.84% 15,563,167
17/08/26 CN¥14.08 -2.76% 24,884,641
14/08/26 CN¥14.48 +3.28% 30,459,083
13/08/26 CN¥14.02 +0.36% 25,149,513
12/08/26 CN¥13.97 +1.31% 29,511,565
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
13.68CNY
Average target price
17.00CNY
Spread / Average Target
+24.27%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300171 Stock